Back to 13F data
Q1 2026
NEUROCRINE BIOSCIENCES INC
Original CUSIPs: 64125C109. This page shows current managers, quarterly changes, and primary SEC sources.
Current managers
1
Combined value
$19.5M
Current managers
1
Calculated from each manager’s latest available 13F.
Total shares
148,141
Aggregated at company level with original CUSIP details preserved.
Combined value
$19.5M
Market values are added across managers reporting the same quarter.
Themes
Unclassified
Local mappings are used only for search and classification.
Four-quarter trend
Four-quarter ownership trend
Manager actions by quarter
Current tracked managers holding this company
| Manager | Quarter | Market value | Shares | Portfolio weight | Current-quarter change | Share change | Value change | SEC source |
|---|---|---|---|---|---|---|---|---|
| Bridgewater Associates Ray Dalio / Bridgewater | Q1 2026 | $19,516,095 | 148,141 | 0.09% | Reduced -1.23% | -1,849 | -$1,756,987 | XML 05/15/2026 |
Original CUSIP details
| Manager | Issuer | CUSIP | Security class | Market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Bridgewater Associates | NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | $19,516,095 | 148,141 | 0.09% | SEC XML |
Quarterly holdings details
| Quarter | Current managers | Combined value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 1 | $1,124,046 | 8,943 | Bridgewater Associates New position |
| Q3 2025 | 1 | $3,234,074 | 23,038 | Bridgewater Associates Increased |
| Q4 2025 | 1 | $21,273,082 | 149,990 | Bridgewater Associates Increased |
| Q1 2026 | 1 | $19,516,095 | 148,141 | Bridgewater Associates Reduced |
Data source
Holdings facts come from SEC 13F information tables. Tickers, company aliases, and themes are used only for search and normalized display, not as a holdings source.